The hygromycin selection serves to eliminate background clones generated by transposon-independent mechanisms, such as those having acquired KRAS and BRAF hotspot mutations through the endogenous MMR deficiency [6]. The gene discussed is BRAF; the disease is mismatch repair cancer syndrome 1.